sanofi glp-1 SOLIQUA® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL & 33 mcg/mL and natural appetite control. Sanofi nabs long-sought FDA approval

For example, studies on 2,500 obese adults taking Mounjaro (tirzepatide) showed a reduction of 1520% in body weight

Novel uses in unconventional areas such as neurodegenerative conditions, non-alcoholic steatohepatitis (NASH), and cardiovascular disease prevention may enhance the therapeutic potential of these medicines

You can prep 2-3 days at a time, or use a hybrid approach: prep some components (proteins, grains) and use convenience items like rotisserie chicken or frozen Clean Eatz Kitchen meals for the rest

Regarding combined incretin agents, the ongoing TREASURE study assesses the effects of the GLP-1/GIP receptor agonist tirzepatide on iohexol-measured GFR in people with CKD with or without diabetes (53)

In LEADER, the use of liraglutide was associated with a 0.4% HbA1c reduction compared with the placebo (Zinman et al., 2018)